Nalbuphine Hydrochloride Injection, Solution
Product Images NDC 0409-1463

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Nalbuphine Hydrochloride (NDC 0409-1463). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula Nalbuphine Hydrochloride (Nalbuphine 01)

Chemical structure of Nalbuphine Hydrochloride, showing its molecular framework including hydroxyl groups and a cyclobutylmethyl substituent.*

FDA Label Image

Novaplus Logo (Nalbuphine 02)

FDA Label Image

Principal Display Panel (10 mg/mL Ampule Label)

Label for Nalbuphine Hydrochloride Injection, 10 mg/mL, a prescription drug by Hospira, Inc. It indicates the product is for intravenous, intramuscular, or subcutaneous use. The label includes dosage strength, route instructions, storage warning to protect from light, and distributor information from Lake Forest, IL.*

FDA Label Image

Principal Display Panel (10 mg/mL Ampule Tray Label)

Label for Nalbuphine Hydrochloride Injection 10 mg/mL single-dose ampuls, distributed by Hospira, Inc. The package contains 10 ampuls of 1 mL each for intravenous, intramuscular, or subcutaneous use. The label includes storage instructions, ingredients, and dosage form information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.